Plastrum Testudinis Stimulates Bone Formation through Wnt/β-catenin Signaling Pathway Regulated by miR-214.
10.1007/s11655-025-4012-9
- Author:
Qing LIN
1
;
Bi-Yi ZHAO
1
;
Xiao-Yun LI
2
;
Wei-Peng SUN
1
;
Hong-Hao HUANG
1
;
Yu-Mei YANG
2
;
Hao-Yu WANG
1
;
Xiao-Feng ZHU
1
;
Li YANG
2
;
Rong-Hua ZHANG
3
Author Information
1. College of Traditional Chinese Medicine, Jinan University, Guangzhou, 510632, China.
2. College of Pharmacy, Jinan University, Guangzhou, 510632, China.
3. College of Pharmacy, Jinan University, Guangzhou, 510632, China. tzrh@jnu.edu.cn.
- Publication Type:Journal Article
- Keywords:
Plastrum Testudinis;
bone formation;
bone mesenchymal stem cell;
miR-214;
osteoporosis
- MeSH:
Animals;
MicroRNAs/genetics*;
Female;
Rats, Sprague-Dawley;
Wnt Signaling Pathway/genetics*;
Osteogenesis/genetics*;
Mesenchymal Stem Cells/cytology*;
Cell Differentiation/drug effects*;
Bone Density/drug effects*;
Ovariectomy;
Osteoporosis/drug therapy*;
beta Catenin/metabolism*;
Rats;
Intercellular Signaling Peptides and Proteins/metabolism*;
Drugs, Chinese Herbal/pharmacology*
- From:
Chinese journal of integrative medicine
2025;31(8):707-716
- CountryChina
- Language:English
-
Abstract:
OBJECTIVE:To investigate the Wnt signaling pathway and miRNAs mechanism of extracts of Plastrum Testudinis (PT) in the treatment of osteoporosis (OP).
METHODS:Thirty female Sprague Dawley rats were randomly divided into 5 groups by random number table method, including sham group, ovariectomized group (OVX), ovariectomized groups treated with high-, medium-, and low-dose PT (160, 80, 40 mg/kg per day, respectively), with 6 rats in each group. Except for the sham group, the other rats underwent bilateral ovariectomy to simulate OP and received PT by oral gavage for 10 consecutive weeks. After treatment, bone mineral density was measured by dual-energy X-ray absorptiometry; bone microstructure was analyzed by micro-computed tomography and hematoxylin and eosin staining; and the expressions of osteogenic differentiation-related factors were detected by immunochemistry, Western blot, and quantitative polymerase chain reaction. In addition, Dickkopf-1 (Dkk-1) was used to inhibit the Wnt signaling pathway in bone marrow mesenchymal stem cells (BMSCs) and miRNA overexpression was used to evaluate the effect of miR-214 on the osteogenic differentiation of BMSCs. Subsequently, PT extract was used to rescue the effects of Dkk-1 and miR-214, and its impacts on the osteogenic differentiation-related factors of BMSCs were evaluated.
RESULTS:PT-M and PT-L significantly reduced the weight gain in OVX rats (P<0.05). PT also regulated the bone mass and bone microarchitecture of the femur in OVX rats, and increased the expressions of bone formation-related factors including alkaline phosphatase, bone morphogenetic protein type 2, collagen type I alpha 1, and runt-related transcription factor 2 when compared with the OVX group (P<0.05 or P<0.01). Meanwhile, different doses of PT significantly rescued the inhibition of Wnt signaling pathway-related factors in OVX rats, and increased the mRNA or protein expressions of Wnt3a, β-catenin, glycogen synthase kinase-3β, and low-density lipoprotein receptor-related protein 5 (P<0.05 or P<0.01). PT stimulated the osteogenic differentiation of BMSCs inhibited by Dkk-1 and activated the Wnt signaling pathway. In addition, the expression of miR-214 was decreased in OVX rats (P<0.01), and it was negatively correlated with the osteogenic differentiation of BMSCs (P<0.01). MiR-214 mimic inhibited Wnt signaling pathway in BMSCs (P<0.05 or P<0.01). Conversely, PT effectively counteracted the effect of miR-214 mimic, thereby activating the Wnt signaling pathway and stimulating osteogenic differentiation in BMSCs (P<0.05 or P<0.01).
CONCLUSION:PT stimulates bone formation in OVX rats through β-catenin-mediated Wnt signaling pathway, which may be related to inhibiting miR-214 in BMSCs.
